Susquehanna International Group, LLP Aytu Biopharma, Inc Call Options Transaction History

Susquehanna International Group, LLP

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	SELL	$0.19 - $3.8 $6,308 - $126,160	-33,200 Reduced 56.46%	25,600 $5,000
Q2 2022 Aug 15, 2022	SELL	$0.46 - $1.08 $1,794 - $4,212	-3,900 Reduced 6.22%	58,800 $41,000
Q1 2022 May 16, 2022	BUY	$1.08 - $1.55 $8,964 - $12,865	8,300 Added 15.26%	62,700 $68,000
Q4 2021 Feb 14, 2022	SELL	$1.35 - $2.95 $214,920 - $469,640	-159,200 Reduced 74.53%	54,400 $73,000
Q2 2021 Aug 11, 2021	BUY	$4.73 - $7.56 $919,985 - $1.47 Million	194,500 Added 1018.32%	213,600 $1.07 Million
Q1 2021 May 17, 2021	BUY	$6.23 - $9.88 $118,993 - $188,708	19,100 New	19,100 $145,000

Ticker AYTU
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 62,432,700
Market Cap $97.4M
Description
Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT f...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.